LEADER 04832nam 22006255 450 001 9910377838803321 005 20200701063436.0 010 $a981-13-3642-3 024 7 $a10.1007/978-981-13-3642-3 035 $a(CKB)4100000010328268 035 $a(DE-He213)978-981-13-3642-3 035 $a(MiAaPQ)EBC6109043 035 $a(PPN)242976549 035 $a(EXLCZ)994100000010328268 100 $a20200212d2019 u| 0 101 0 $aeng 135 $aurnn|008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aNovel Drug Delivery Technologies $b[electronic resource] $eInnovative Strategies for Drug Re-positioning /$fedited by Ambikanandan Misra, Aliasgar Shahiwala 205 $a1st ed. 2019. 210 1$aSingapore :$cSpringer Singapore :$cImprint: Springer,$d2019. 215 $a1 online resource (XXIV, 431 p. 62 illus., 40 illus. in color.) 311 $a981-13-3641-5 327 $aChapter 1. Poorly water soluble drugs and formulation strategies to improve oral bioavailability -- Chapter 2. Buccal and intraoral drug delivery: Potential alternative to conventional therapy -- Chapter 3. Gastro-retentive drug delivery Systems: Current strategies and challenges -- Chapter 4. Peyer?s patch: Targeted drug delivery for therapeutics benefits -- Chapter 5. Colonic drug delivery systems as Multi-unit potential: Therapeutic strategies and opportunities -- Chapter 6. Controlled and prolonged drug delivery systems: Therapeutics needs and formulation strategies -- Chapter 7. Transdermal drug administration: Emerging techniques and improved patient compliance -- Chapter 8. Inhalation drug therapy: Emerging trends in Nasal and pulmonary drug delivery -- Chapter 9. Ophthalmic and otic drug administration: Novel approaches and challenges -- Chapter 10. Targeted drug delivery to brain: Challenges and formulation approaches -- Chapter 11. Opportunities and challenges in targeted carrier based drug delivery: Increased efficacy & reduced toxicity. 330 $aThe application of drug delivery is a valuable, cost-effective lifecycle management resource. By endowing drugs with new and innovative therapeutic benefits, drug delivery systems extend products? profitable lifecycle, giving pharmaceutical companies competitive and financial advantages, and providing patients with improved medications. Formulation development is now being used to create new dosage forms for existing products, which not only reduces the time and expense involved in new drug development, but also helps with regard to patent protection and bypassing existing patents. Today?s culture demands convenience, a major factor determining adherence to drug therapy. Over the past few years, patient convenience-oriented research in the field of drug delivery has yielded a range of innovative drug-delivery options. As a result, various drug-delivery systems, including medicated chewing gums, oral dispersible tablets, medicated lozenges and lollipops, have now hit the market and are very popular. These dosage forms offer a highly convenient way to dose medications, not only for special population groups with swallowing difficulties, such as children and the elderly, but for the general populace as well. This book provides valuable insights into a number of formulation design approaches that are currently being used, or could be used, to provide new benefits from existing drug molecules. 606 $aPharmacology 606 $aPharmacy 606 $aMedicinal chemistry 606 $aNanochemistry 606 $aPharmacology/Toxicology$3https://scigraph.springernature.com/ontologies/product-market-codes/B21007 606 $aDrug Safety and Pharmacovigilance$3https://scigraph.springernature.com/ontologies/product-market-codes/H69010 606 $aMedicinal Chemistry$3https://scigraph.springernature.com/ontologies/product-market-codes/C28000 606 $aPharmacy$3https://scigraph.springernature.com/ontologies/product-market-codes/F00008 606 $aNanochemistry$3https://scigraph.springernature.com/ontologies/product-market-codes/C33000 615 0$aPharmacology. 615 0$aPharmacy. 615 0$aMedicinal chemistry. 615 0$aNanochemistry. 615 14$aPharmacology/Toxicology. 615 24$aDrug Safety and Pharmacovigilance. 615 24$aMedicinal Chemistry. 615 24$aPharmacy. 615 24$aNanochemistry. 676 $a615.6 702 $aMisra$b Ambikanandan$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aShahiwala$b Aliasgar$4edt$4http://id.loc.gov/vocabulary/relators/edt 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910377838803321 996 $aNovel Drug Delivery Technologies$92135478 997 $aUNINA